Atlas Venture Fund X, L.P.'s Net Worth

$533 Million

Who is Atlas Venture Fund X, L.P.?

Atlas Venture Fund X, L.P. has an estimated net worth of $533 Million. This is based on reported shares across multiple companies, which include Generation Bio Co., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., and AVROBIO, Inc..

SEC CIK

Atlas Venture Fund X, L.P.'s CIK is 0001628098

Past Insider Trading and Trends

2018 was Atlas Venture Fund X, L.P.'s most active year for acquiring shares with 6 total transactions. Atlas Venture Fund X, L.P.'s most active month to acquire stocks was the month of May. 2023 was Atlas Venture Fund X, L.P.'s most active year for disposing of shares, totalling 34 transactions. Atlas Venture Fund X, L.P.'s most active month to dispose stocks was the month of November. 2019 saw Atlas Venture Fund X, L.P. paying a total of $15,000,003.50 for 825,056 shares, this is the most they've acquired in one year. In 2023 Atlas Venture Fund X, L.P. cashed out on 1,033,086 shares for a total of $53,343,252.37, their largest year based on trade value.